2 completed. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow RDO Pharm.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung Cancer 99mTc-3PRGD2 injection - Lung Cancer, Lymph Node Metastasis | Phase 3 | Completed | RDO Pharm. | 409 | 2019-10-12 | 2024-07-01 |
| A Study of 99mTc-3PRGD2 Injection in Healthy Volunteers 99mTc niacinamide polyethylene glycol bicyclic RGD peptide (99mTc-3PRGD2) - Healthy | Phase 1 | Completed | RDO Pharm. | 10 | 2018-12-12 | 2019-08-08 |
Lung Neoplasms (1) · Lymphatic Metastasis (1)
Technetium (1)
China (2)
Zhaohui Zhu, MD, PhD (1) · Zhaohui Zhu, professor (1)